ArmA

PROCEDURE2 trials

Sponsors

Nagoya University, Graduate School of Medicine, Asian Institute of Gastroenterology, India

Conditions

GERDRefluxReflux Esophagitisresectable pancreatic cancer with less than 180 degree portal vein abutment

Unknown Phase

Randomized phase II study of neoadjuvant chemoradiotherapy (S-1+radiation) for resectable pancreatic cancer with less than 180 degree portal vein abutment

RecruitingJPRN-UMIN000027633

Nagoya University, Graduate School of Medicineresectable pancreatic cancer with less than 180 degree portal vein abutment

Start: 2017-07-01Target: 56Updated: 2025-07-18

Role of ARMA in Selective Subset of Refractory GERD Patients.

CompletedNCT05899491

Asian Institute of Gastroenterology, IndiaGERD, Reflux, Reflux Esophagitis

Start: 2023-03-30End: 2023-12-30Updated: 2025-04-04